Objective-Type 1 diabetes mellitus (T1D) patients have an increased risk of cardiovascular disease despite high levels of high-density lipoproteins (HDL). Apolipoprotein M (apoM) and its ligand sphingosine 1-phospate (S1P) exert many of the anti-inflammatory effects of HDL. We investigated whether apoM and S1P are altered in T1D and whether apoM and S1P are important for HDL functionality in T1D. Approach and Results-ApoM and S1P were quantified in plasma from 42 healthy controls and 89 T1D patients. HDL was isolated from plasma and separated into dense, medium-dense, and light HDL by ultracentrifugation. Primary human aortic endothelial cells were challenged with tumor necrosis factor-α in the presence or absence of isolated HDL. Proinflammatory adhesion molecules E-selectin and vascular cellular adhesion molecule-1 were quantified by flow cytometry. Activation of the S1P 1 -receptor was evaluated by analyzing downstream signaling targets and receptor internalization. There were no differences in plasma levels of apoM and S1P between controls and T1D patients, but the apoM/S1P complexes were shifted from dense to light HDL particles in T1D. ApoM/S1P in light HDL particles from women were less efficient in inhibiting expression of vascular cellular adhesion molecule-1 than apoM/S1P in denser particles. The light HDL particles were unable to activate Akt, whereas all HDL subfractions were equally efficient in activating Erk and receptor internalization. Conclusions-ApoM/S1P in light HDL particles were inefficient in inhibiting tumor necrosis factor-α-induced vascular cellular adhesion molecule-1 expression in contrast to apoM/S1P in denser HDL particles. T1D patients have a higher proportion of light particles and hence more dysfunctional HDL, which could contribute to the increased cardiovascular disease risk associated with T1D. Visual Overview-An online visual overview is available for this article. 
R ecent advances in our understanding of high-density lipoprotein (HDL) functionality 1 have challenged the concept that the level of HDL, usually measured as its cholesterol content, is a valid HDL predictor of the risk of cardiovascular disease (CVD). 2 This is particularly relevant in clinical situations where risk of CVD is high yet HDL-cholesterol (HDL-C) levels are normal or increased. Type 1 diabetes mellitus (T1D) is characterized by an excessive risk for CVD, yet HDL-C values are usually average or often increased in this condition. 3 Furthermore, although HDL-C has been shown to correlate inversely with CVD risk in these subjects, 4 very high HDL-C levels have been shown to be associated with increased risk of CVD in T1D. 5 This raised the possibility that the large, lipid-rich HDL particles found in subjects with high HDL-C may have reduced functionality in relation to the development of CVD. Similarly, the EPIC-Norfolk study found that in the group of subjects with very high HDL-C, HDL-C was positively associated with CVD risk. 6 
See accompanying editorial on page 1018
Several HDL peptides thought to be important in mediating the antiatherosclerotic properties of HDL such as paroxonase and platelet-activating factor are known to be carried on the denser fractions of HDL. 7 The possibility that increasing HDL size might alter their distribution and functionality has been studied before in a study by Ashby et al 8 where they found that HDL 2 particles were less anti-inflammatory than HDL 3 . This effect was not because of altered apolipoprotein AI (apoAI)/apoAII composition, and the underlying mechanism is still unknown.
of reverse cholesterol transport and to play a role in the formation of pre-β-HDL and in the antioxidative properties of HDL. 10 In addition, apoM has also been shown to be a carrier for the endothelial regulator sphingosine 1-phosphate (S1P), which through its action on endothelial S1P 1 receptors contributes to the vasculoprotective action of HDL. 11 In mice, diabetic aortas bind more monocytes than nondiabetic aortas and the addition of 100 nmol/L S1P reduces the expression of intercellular adhesion molecule and vascular cellular adhesion molecule (VCAM-1) shows that S1P is important in preventing proinflammatory events in diabetes mellitus. 12 In a study by Denimal et al, 13 S1P was shown to be decreased in both HDL 2 and HDL 3 particles in T1D patients compared with healthy controls. Moreover, recently, HDL from subjects with T2D was shown to have reduced S1P levels and conferred impaired protection of isolated cardiomyocytes from oxidative stress. 14 Plasma levels of apoM are known to be decreased in T2D, and plasma S1P has been shown to correlate with kidney dysfunction in T2D patients. 15, 16 In mice with T1D, S1P is increased as compared with control mice. 17 In a study of lipoprotein compositional differences between T1D patients and controls, using parts of the same cohort as in the present study, we have observed that the apoM content, measured by high-pressure liquid chromatography, was increased in lighter density HDL subfractions in T1D. However, the high-pressure liquid chromatography method used was not entirely specific for apoM and the effect of T1D on apoM and S1P plasma levels in humans is unknown. 18 In this study, we aimed to systematically measure apoM and S1P in plasma and in different HDL subpopulations from 42 healthy controls and 89 T1D patients using an apoM ELISA and an LC-MS/MS (liquid chromatography-tandem mass spectrometry) technique specific for S1P. In addition, we investigated the anti-inflammatory effects on cultured endothelium of low, medium, and dense HDL particles and the importance for apoM/S1P-functionality when present on different HDL subpopulations.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Patient Characteristics
The study population was mostly Hispanic and white, and both sexes were well matched for body mass index and age (Table 1) . HDL-C was increased in both sexes in T1D compared with controls, whereas apoAI was only increased in T1D women (Table 1 ; Figure 1 ). Analysis of apoM and S1P plasma levels revealed that there were no differences between T1D and controls ( Figure 1 ). The plasma apoM/HDL-C and S1P/ HDL-C ratios were overall and by sex subgroup lower in T1D versus controls (Table 1) . This suggests that apoM/S1P does not increase in T1D subjects despite the fact that they have higher HDL-C values than controls, thus resulting in apoM/ S1P-deficient HDL per unit cholesterol. Furthermore, T1D with high HDL-C defined as ≥85th percentile of the control group HDL-C distribution had even lower apoM/HDL-C and S1P/HDL-C ratios despite having a higher apoM concentration than those with HDL-C values <85th percentile (Table I in the online-only Data Supplement). The reduction in apoM and S1P when expressed per unit apoAI was less significant (Table 1) .
ApoM/S1P Complex Shifts From Dense to Light HDL Particles in T1D
To study the cholesterol profile and determine on which kind of HDL particles the apoM/S1P complex was located, dense, medium, and light HDL particles were isolated from control and T1D plasma by density gradient ultracentrifugation. ApoM and S1P were mostly present on dense and mediumdense HDL particles in controls, but there was a significant shift of the apoM/S1P complex toward light HDL particles in T1D (Figure 2 ). In both sexes, cholesterol was increased in the light HDL particles ( Figure 3A ) and decreased in the dense HDL particles in T1D patients when compared with controls ( Figure 3C ). Interestingly, in women, both apoM and S1P followed that pattern and were significantly increased in the light T1D HDL particles, whereas in male patients, there was a similar although nonsignificant trend ( Figure 3 ). There were no differences in any of the analytes in the middle-density HDL subfraction fraction ( Figure 3B ). In the dense HDL particles, the cholesterol was decreased in both sexes, as was apoM, whereas S1P was significantly decreased only in T1D men ( Figure 3C ). An explanation for the significant large relative increase in apoM and S1P in the light HDL fraction with only small nonsignificant relative decrease in the denser fractions may be that even a small absolute shift of S1P from the denser fraction, which has a high S1P concentration, to the lighter fractions, which has a lower S1P level, results in a large relative increase in apoM and S1P in the light fractions with only a small relative decrease in apoM and S1P in the denser fractions.
Thus, there was a redistribution of cholesterol in T1D to lighter density HDL particles in both sexes with a similar distribution of apoM/S1P although this varied by sex.
The correlation between apoM and S1P in HDL was strong (with spearman correlation coefficient, r S =0.95) as compared with the plasma (r S =0.23; Figure 4A ). The recovery of apoM and S1P in HDL after isolation from plasma was 88.5±13% and 42.7±11%, respectively ( Figure 4B ).
Correlation Between Key Parameters and ApoM and S1P in Plasma and HDL Fractions
We analyzed the correlation between apoM and S1P and different parameters in both plasma and isolated HDL ( Table 2 ). There was a strong positive correlation between plasma apoM and HDL-C but not with low-density lipoprotein-cholesterol, whereas plasma S1P did not correlate with either of the lipoproteins in controls and T1D. The correlation between apoM and HDL-C is related to apoM in the light and medium density HDL and not to apoM in dense HDL subfraction. Although HDL-C did not correlate with total plasma S1P, it correlated strongly with lighter density S1P but not that in dense HDL subfraction. In both T1D and control groups, HDL-C was inversely related to the apoM/HDL-C ratio. This suggests that the finding of a lower apoM/HDL-C ratio in the T1D group reflects a more general relationship between HDL-C and apoM and is lower in the T1D because they generally have higher HDL-C. However, the apoA1/apoM ratio does not vary with HDL-C levels suggesting that it is the change in the ratio of the content of cholesterol to apoM, that is, the HDL size rather than the number of HDL particles better reflected by apoAI that drives this association. There was a positive relationship between age and apoM in plasma and dense HDL subfraction, which has been reported in women previously.
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Light HDL Particles Are Less Antiinflammatory Than Dense HDL Particles
To test the anti-inflammatory properties of HDL isolated from controls and T1D subjects, we pooled HDL from the different subfractions to generate total HDL and added it together with tumor necrosis factor-α to primary human aortic endothelial cells. The presence of proinflammatory adhesion molecules E-selectin and VCAM-1 was quantified on the endothelial surface by flow cytometry (as visualized in Figure I in the online-only Data Supplement). When comparing total HDL from controls and T1D, there was no difference between the groups in its inhibitory effect on E-selectin and VCAM-1 ( Figure 5A ). High HDL-C is thought to protect against CVD, but T1D patients with high HDL may not benefit from this protection. Therefore, we hypothesized that the HDL in T1D patients with high HDL levels could have an altered functionality. We separated the T1D patients into those with high HDL-C (≥85% percentile) from those with lower HDL-C (<85% percentile; Table I in the online-only Data Supplement shows patient characteristics of these groups). The concentration of HDL-C loaded to the cell cultures was purposely chosen to reflect the plasma HDL-C of the different groups, that is, in the >85% percentile group, cells were exposed to a higher concentration of HDL-C than in the <85% percentile group. Despite the fact that patients with high HDL-C had a somewhat higher amount of S1P, there was no difference in the HDL functionality between the patients with high and low HDL-C ( Figure 5B ). Even Patients with T1D (n=89) who attended the Diabetes Clinic at the Diabetes Institute of University of Miami and 42 healthy individuals were enrolled in the study. Blood samples were drawn after an overnight fast, and parameters were measured as described in the Materials and Methods in the online-only Data Supplement. Statistical analysis between groups was made by Student t test. apoM indicates apolipoprotein M; BMI, body mass index; CRP, C-reactive protein; F, female; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein-cholesterol; LDL, low-density lipoprotein; M, male; S1P, sphingosine 1-phospate; and T1D, type 1 diabetes mellitus. *P<0.05, †P<0.001, and ‡P>0.01.
though there was no significant inhibition by either group on VCAM-1 in Figure 5B , there was a similar trend to that in Figure 5A .
Next, we tested the functionality of the different HDL subfractions separately. As women were shown to have the strongest shift of apoM and S1P from dense to light HDL particles ( Figure 3) , we hypothesized that they would have the strongest alteration in the functionality between the subfractions related to apoM and S1P. Hence, we tested the functionality of HDL subfractions from women.
When loading HDL based on the cholesterol distribution between the different HDL particles in plasma, that is, high HDL-C levels and low S1P levels in light particles and low HDL-C and high S1P levels in dense HDL particles, we found that light HDL particles from both controls and T1D were less efficient in inhibiting E-selectin and VCAM-1 compared with the dense HDL particles ( Figure 6A ). In T1D-HDL, the medium-dense particles also did not significantly inhibit VCAM-1, whereas in healthy controls, medium-dense particles were as functional as dense particles ( Figure 6A) .
When loading the same amount of S1P (100 nmol/L) in all HDL subfractions, the light HDL was still unable to inhibit VCAM-1 but did inhibit E-selectin in both controls and T1D ( Figure 6B ). In T1D patients, none of the HDL subfractions alone could significantly inhibit VCAM-1, whereas both the dense and medium-dense particles from the control HDL were functional ( Figure 6B ). To elucidate whether the disparity in the results from A and B were because of an actual difference in functionality between control HDL and T1D-HDL or because of experimental variation, we conducted a doseresponse experiment comparing medium-HDL from controls and T1D. We found that there was no difference in efficacy of medium-HDL particles from controls and T1D in inhibiting VCAM-1 expression ( Figure 6C ). Interestingly, HDL containing 300 nmol/L S1P could completely inhibit the tumor necrosis factor-α-induced VCAM-1 expression clearly showing the anti-inflammatory property of the apoM/S1P complex in HDL.
These data show that light HDL particles from both controls and T1D are less inhibitory on proinflammatory adhesion molecules on the endothelial surface, but the functionality of Figure 3 . Cholesterol, apolipoprotein M (apoM), and sphingosine 1-phospate (S1P) content in high-density lipoprotein (HDL) subfractions by sex. HDL from 42 controls and 78 type 1 diabetes mellitus (T1D) patients was isolated from plasma and separated into light particles (A), medium-dense (B), and dense (C) by ultracentrifugation as described in the Materials and Methods in the online-only Data Supplement. ApoM was measured by ELISA and S1P by LC-MS/MS (liquid chromatography-tandem mass spectrometry). Statistical analysis between groups was made by 2-way ANOVA with subsequent pair-wise comparisons using the Tukey method for multiple comparisons. Data are shown as mean±SEM. HDL-D indicates dense HDL subfraction; HDL-L, low-density HDL subfractions; and HDL-M, middledensity HDL subfraction.
HDL with regard to apoM/S1P does not seem to be altered in T1D compared with controls, supporting our findings in Figure 5 . However, when the apoM/S1P complex is present on light HDL particles, it loses its inhibitory effect on VCAM-1 and T1D-patients have more of these particles.
Activation of the S1P 1 Receptor by the Light HDL Particles
In an effort to elucidate why the light HDL particles were unable to inhibit VCAM-1, we investigated whether all the HDL subfractions could activate the S1P 1 -receptor, which is known to mediate the anti-inflammatory properties of the apoM/S1P complex on the endothelial surface. 20, 21 Both Akt and Erk signaling pathways have been shown to be downstream targets of S1P 1 11 and hence we tested whether dense, medium, and light HDL particles containing the same amount of S1P could activate these pathways. In this experiment, we compared T1D-HDL with an HDL pool purified from 5 healthy donors. 22 We found that dense particles could activate Akt, whereas medium particles had lower effect and light particles were unable to induce phosphorylation of Akt ( Figure 7A ). In contrast, all HDL subfractions could activate Erk ( Figure 7B ). Internalization of G-coupled receptors is a mechanism to avoid overstimulation of the receptor and this has been shown also for S1P 1 . 11 We overexpressed S1P 1 -GFP (green fluorescent protein) constructs in HEK293 (human embryonic kidney 293) cells and followed the internalization of the receptor on exposure of dense, medium, and light HDL from T1D and in-house purified HDL containing the amount of S1P required to induce receptor internalization in our experiments (150 nmol/L). We observed that all HDL subfractions could internalize S1P 1 ( Figure 7C ), suggesting that light HDL particles containing the same amount of S1P as denser HDL particles can activate the S1P 1 receptor; however, downstream targets are activated differently depending on the density of the HDL particle.
Discussion
HDL is thought to protect against CVD. 23 Lately, this hypothesis has been questioned in large clinical trials where genetic variants with increased HDL-C levels did not correlate with lower risk of CVD. 24 However, HDL particles are highly diverse in their composition. They have high protein content (30%-70% by weight), and to date, 100 different proteins have been characterized in the HDL proteome raising the question as to whether quality rather than quantity is important in evaluating HDL functionality. 25 HDL exerts its cardioprotective effects through several actions including reverse cholesterol transport, antioxidative, anti-inflammatory, and antibacterial effects.
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T1D patients have higher risk of CVD despite normal to high levels of HDL and thereby T1D patients may be an important Recovery and correlation of sphingosine 1-phospate (S1P) and apolipoprotein MM (apoM) in plasma and isolated high-density lipoprotein (HDL). Eighty-nine patients with type 1 diabetes mellitus (T1D) who attended the Diabetes Clinic at the Diabetes Institute of University of Miami and 42 healthy individuals were enrolled in the study. Blood samples were drawn after an overnight fast. ApoM was measured by ELISA and S1P by LC-MS/MS (liquid chromatography-tandem mass spectrometry). HDL from 42 controls and 78 T1D patients was isolated from plasma and separated into dense, medium-dense, and light particles by ultracentrifugation as described in the Materials and Methods in the online-only Data Supplement. A, Left, Correlation was analyzed between apoM and S1P in plasma from both controls and T1D patients (n=131); right, correlation was analyzed between apoM and S1P in isolated HDL from both controls and T1D patients (n=362). B, Recovery of apoM (left) and S1P (right) in isolated HDL compared with plasma was calculated as described in the Materials and Methods in the online-only Data Supplement. Correlation analysis was made according to Spearman correlation coefficient, r S .
group in which to study HDL functionality. Here, we show that light density HDL particles are less anti-inflammatory than denser HDL particles in both T1D patients and healthy controls. In addition, we found that when the apoM/S1P complex is located on light HDL particles, it loses its inhibitory effects on the expression of proinflammatory adhesion molecules on the endothelial surface. T1D patients have increased amounts of lighter density HDL particles and hence have more ineffective HDL with respect to apoM/S1P functionality.
Plasma levels of S1P and apoM are decreased in T2D patients 14 , 15 but have not been studied in human T1D. Here, we show that there are no differences in plasma levels of apoM and S1P between controls and T1D. The disparity between apoM and S1P levels in T1D and T2D might be explained by the rapid clearance of HDL in T2D with increased clearance from the circulation because of an altered proteome with reduced levels of apoAI and increased presence of serum amyloid A. 26, 27 Moreover, insulin resistance is common in T2D, and in rats, insulin resistance was shown to decrease apoM expression in the liver. 28 In contrast, total HDL-C and specifically the pool of cholesterol-enriched lighter density HDL is increased in T1D 3 leading to a relative deficiency of apoM and S1P per unit cholesterol in this HDL pool. T1D patients have increased lipoprotein lipase activity leading to increased hydrolysis of Patients with T1D (n=89) who attended the Diabetes Clinic at the Diabetes Institute of University of Miami and 42 healthy individuals were enrolled in the study. Blood samples were drawn after an overnight fast, and parameters were measured as described in the Materials and Methods in the online-only Data Supplement. Statistical correlation between groups was according to Pearson. apoM indicates apolipoprotein M; BMI, body mass index; CRP, C-reactive protein; HbA1c, glycated hemoglobin; HDL-D, dense high-density lipoprotein subfraction; HDL-L, low-density high-density lipoprotein subfraction; HDL-M, middle-density high-density lipoprotein subfraction; LDL-C, low-density lipoprotein-cholesterol; S1P, sphingosine 1-phospate; and T1D, type 1 diabetes mellitus.
Cells in *P<0.05.
triglyceride-rich HDL particles, which leads to assembling of surface components from these particles into larger HDL particles. 29 Adiponectin is also associated with increased large HDL-C particles in T1D; however, the mechanism behind this is not known. 29 The fall in the apoM/HDL-C and S1P/HDL-C ratios in T1D reflects a selective enrichment of cholesterol in HDL, whereas the levels of apoM and S1P are stable.
The functionality of HDL subfractions has not been well studied. In a recent review of studies investigating associations between HDL 2 and HDL 3 and CVD, a consistent relationship with either of these subfractions and CVD was not found. 30 However, several recent studies have found that HDL 3 cholesterol is inversely related to cardiovascular events, 31 carotid plaque area, 32 and to the necrotic lipid core. 33 Moreover, functional studies have demonstrated that the HDL 3 subfraction is less prone to oxidation because of greater paraoxonase 1 activity 34 and it seems to inhibit low-density lipoprotein oxidation to a greater extent than HDL 2 . 35 The surface curvature and lipid and protein composition of HDL change when the particle size increases, which may result in changes in the structural conformation of apolipoproteins on the surface. 36 For example, it has been demonstrated that apoAI on small, dense HDL particles is a much better ligand for ABCA1 than for apoAI on large HDL particles 37 and lecithin-cholesterol acyltransferase activity is inversely correlated with HDL particle size in the HDL 3 subclass. 38 In contrast, the opposite is true for HDL binding to ABCG1 39 and SR-BI (scavenger receptor class B member 1), 40 and HDL 2 is the preferred substrate for hepatic lipase as compared with low-density lipoprotein and HDL 3 . 41 Such differences in binding activity have been suggested to Figure 5 . High-density lipoprotein (HDL) functionality in controls and type 1 diabetes mellitus (T1D). HDL from 42 controls and 78 T1D patients were isolated from plasma and separated into dense, medium-dense, and light particles by ultracentrifugation as described in the Materials and Methods in the online-only Data Supplement. Apolipoprotein M (ApoM) was measured by ELISA and sphingosine 1-phospate (S1P) by LC-MS/MS (liquid chromatography-tandem mass spectrometry). Isolated HDL was desalted, and the buffer was changed to serum-free cell medium by sequential centrifugation in 3-kDa filter tubes. Total HDL was generated by pooling equal amounts of all HDL subfractions. Human aortic primary endothelial cells (HAEC) were incubated with tumor necrosis factor (TNF)-α in presence or absence of HDL for 4 h. Proinflammatory adhesion molecules E-selectin and vascular cellular adhesion molecule (VCAM)-1 were quantified on the endothelial surface by flow cytometry. White bars represent healthy controls, and black bars represent T1D patients. Nonstim. equals nonstimulated and the HDL in the control contained 100 nmol/L S1P. A, All HDL subfractions were mixed to generate total HDL and added to HAECs with the following HDL-C or S1P concentrations: control S1P; 0.2 mmol/L HDL-C+100 nmol/L S1P, T1D S1P; 0.3 mmol/L HDL-C+100 nmol/L S1P, control HDL-C; 0.3 mmol/L HDL-C+150 nmol/L S1P, T1D HDL-C; 0.3 mmol/L HDL-C+141 nmol/L S1P. B, T1D patients were separated into >85 percentile HDL-C or <85 percentile HDL-C and added as total HDL with the following HDL-C or S1P-concentration: high HDL women: 0.22 HDL-C+100 nmol/L S1P; low HDL women: 0.15 mmol/L HDL-C+75 nmol/L S1P; high HDL men: 0.195 mmol/L HDL-C+100 nmol/L S1P; low HDL men: 0.1375 mmol/L HDL-C+83 nmol/L S1P. Statistical analysis to determine differences between groups was done by 1-way ANOVA with Tukey multiple comparison test. Stars on bars indicate significance compared with TNFα. Experiments were repeated 3 times. *P<0.05, **P<0.01, ****P<0.0001. Data are shown as mean±SD. MFI indicates mean fluorescent intensity.
result from differences in apoAI conformation in the different HDL subfractions. Importantly, HDL 3 is known to be more anti-inflammatory than HDL 2 , as shown by its inhibitory effect on VCAM-1 in human umbilical vein endothelial cells. 8 This effect was not because of apolipoprotein composition; however, when applying reconstituted HDL, neither delipidated apoA1 nor lipids on their own had any affect suggesting that both are required for HDL protective effects. 8 We now provide additional evidence based on apoM/S1P functionality that light HDL particles are less anti-inflammatory than dense particles. When pooling all subfractions together regenerating total HDL, there was no difference in HDL functionality between controls and T1D patients. Equal volumes of the subfractions were mixed to generate total HDL, which represents the distribution in plasma meaning that in controls, most HDL-C will be present in mediumdense particles, whereas in T1D, most HDL-C will be present in medium and light particles. The light HDL particles have decreased anti-inflammatory effects but as judged by the experiment with total HDL, they do not affect the function of denser particles. As shown in our dose-response experiment, the functionality of medium-dense HDL in T1D patients is not altered when compared with controls when normalized to S1P concentrations, which further supports our findings in the experiments investigating total HDL. Interestingly, when present on light HDL particles, the apoM/S1P complex is unable to exert inhibitory effects on VCAM-1 showing that the isolated interaction between the endothelium and the different HDL subfractions is important for endothelial functionality. By analogy, changes in HDL subfraction size and composition may cause alterations in the conformation of apoM on the various HDL subfractions and thus the interaction between apoM/S1P and the S1P receptors on the cell surface.
It is well established that HDL lacking apoM and S1P are less anti-inflammatory than HDL containing the apoM/ S1P complex. 11, 20, 21 Moreover, the S1P content in HDL from patients with coronary artery disease is decreased and has reduced vasodilatory properties, which could be restored with S1P loading. 42 We now show that the HDL-associated apoM/ S1P complex shifts from dense to light density HDL particles in T1D, which decreases its inhibitory effect on VCAM-1. S1P followed apoM closely in the distribution between the HDL subfractions, which is in agreement with apoM being the S1P carrier in HDL. Increased inflammation and endothelial dysfunction have been proposed as risk factors underlying the increased CVD risk in diabetes mellitus. 43, 44 S1P exerts its inhibitory effect on VCAM-1 via binding to the S1P 1 receptor 20, 21 and hence dysfunctional delivery of the endothelial protective S1P to S1P 1 could contribute to the endothelial dysfunction in T1D. When investigating downstream signaling targets of the S1P 1 receptor, we found that light particles could not activate Akt despite containing the same amounts of S1P as dense and medium HDL particles. However, when present on light particles, the apoM/S1P complex could activate Erk and light particles could internalize the S1P 1 receptor similarly as dense and medium-dense particles. These results suggest that when present on light HDL particles, the apoM/S1P complex can interact with the S1P 1 receptor but that downstream targets are differently activated by apoM/ S1P depending on which HDL subfraction it is present. Akt is regulated by the phosphoinositide 3-kinase family responsible in forming 3-phosphoinositides. 45 Phosphoinositide 3-kinase Figure 7 . All high-density lipoprotein (HDL) subfractions internalize the sphingosine 1-phospate (S1P) 1 receptor but downstream signaling pathways are differently activated. HDL from 19 to 30 type 1 diabetes mellitus (T1D) female patients was isolated from plasma and separated into dense, medium-dense, and light particles by ultracentrifugation as described in the Materials and Methods in the onlineonly Data Supplement. Apolipoprotein M (ApoM) was measured by ELISA and S1P by LC-MS/MS (liquid chromatography-tandem mass spectrometry). Because of limited amount of samples from controls enrolled in this study, HDL subfractions studied in A-C are from T1D and compared with in-house purified HDL. A and B, Human aortic primary endothelial cells were incubated with HDL for 6 min containing the same amount of S1P (50 nmol/L). W146 (S1P 1 inhibitor) was added 30 min before HDL-stimulation and was present during the HDL-stimulation. Nonstim. equals nonstimulated. A, Phospho-Akt and (B) phsopho-Erk was evaluated using Western blot according to the Materials and Methods in the online-only Data Supplement. Experiments were performed in triplicates. Statistical analysis to determine differences between groups was done by 1-way ANOVA with Tukey multiple comparison test. Stars on bars indicate significance compared with nonstimulated. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Data are shown as mean±SD. C, HEK293 (human embryonic kidney 293) cells overexpressing S1P 1 -GFP (green fluorescent protein) constructs were nonstimulated or exposed to HDL isolated from T1D or in-house purified HDL containing enough S1P to induce internalization (150 nmol/L S1P) for 30 min in cell incubator. Internalization of the receptor was analyzed by confocal microscopy and representative images are shown. Scale bar, 20 μm.
is activated downstream of G-coupled receptors and the key effector is Akt. 46 Activation of phosphoinositide 3-kinase regulates endothelial cell barrier functions in endothelial cells, 47 a function in which the apoM/S1P complex has been proven to be involved. 11 As indicated by our results, the apoM/S1P complex can no longer activate this pathway when present on light HDL particles. In contrary, Erk is the effector kinase of the Ras-Raf-MEK-ERK pathway, which is activated by an upstream G-coupled protein (RAS) leading to phosphorylation of 3 kinases: RAF, MEK, and Erk. 48 This signaling cascade mediates extracellular signals into an intracellular coordinate of survival, migration, and cellular growth. 49 Our results suggest that S1P 1 is activated by the apoM/S1P complex located at all HDL subfractions; however, G proteins regulating downstream signaling pathways seem to be differently activated depending on the density and size of the HDL particle. These results suggest that differences in signaling may be the reason why E-selectin was less affected by the different HDL subfractions as compared with VCAM-1.
When comparing the correlation between apoM and S1P in plasma and in isolated HDL, there was a low correlation in plasma but a very high correlation in HDL. This difference can be explained by the fact that 60% of plasma S1P is transported by HDL and 40% by albumin, whereas HDL is the main carrier of plasma apoM. When comparing the recovery of apoM and S1P in the isolated HDL compared with plasma, we found that the recovery for S1P was also proportionately lower than for apoM for this reason.
To conclude, in T1D patients, in particular in the female patients, the apoM/S1P complex is shifted toward the light HDL particles and the concentration of these dysfunctional particles is increased in T1D. Our study reveals that the cholesterol-rich light density HDL particles exert lower antiinflammatory effects on endothelium than dense HDL particles. Moreover, the density of the HDL particle seems to regulate which downstream signaling pathways of S1P 1 are activated. Our results may contribute to an increased understanding of the mechanisms underlying the increased risk of CVD in T1D patients. However, these results need to be confirmed and further investigated in larger cohorts and in vivo by additional functional studies.
